JP2005505274A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505274A5
JP2005505274A5 JP2003530854A JP2003530854A JP2005505274A5 JP 2005505274 A5 JP2005505274 A5 JP 2005505274A5 JP 2003530854 A JP2003530854 A JP 2003530854A JP 2003530854 A JP2003530854 A JP 2003530854A JP 2005505274 A5 JP2005505274 A5 JP 2005505274A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
polypeptide
angiogenesis
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003530854A
Other languages
English (en)
Japanese (ja)
Other versions
JP4486815B2 (ja
JP2005505274A (ja
Filing date
Publication date
Priority claimed from AUPR7973A external-priority patent/AUPR797301A0/en
Priority claimed from AUPR7974A external-priority patent/AUPR797401A0/en
Priority claimed from AUPR8210A external-priority patent/AUPR821001A0/en
Priority claimed from AUPR8532A external-priority patent/AUPR853201A0/en
Priority claimed from AUPR8838A external-priority patent/AUPR883801A0/en
Priority claimed from AU2002951032A external-priority patent/AU2002951032A0/en
Application filed filed Critical
Priority claimed from PCT/AU2002/001282 external-priority patent/WO2003027285A1/en
Publication of JP2005505274A publication Critical patent/JP2005505274A/ja
Publication of JP2005505274A5 publication Critical patent/JP2005505274A5/ja
Publication of JP4486815B2 publication Critical patent/JP4486815B2/ja
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003530854A 2001-09-27 2002-09-19 ヒト血管形成遺伝子に対するｄｎａ配列 Expired - Fee Related JP4486815B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AUPR7973A AUPR797301A0 (en) 2001-09-27 2001-09-27 Dna sequences for human angiogenesis genes i
AUPR7974A AUPR797401A0 (en) 2001-09-27 2001-09-27 Dna sequences for human angiogenesis genes ii
AUPR8210A AUPR821001A0 (en) 2001-10-11 2001-10-11 Dna sequences for human angiogenesis gene iv
AUPR8532A AUPR853201A0 (en) 2001-10-29 2001-10-29 Dna sequences for human angiogenesis genes vi
AUPR8838A AUPR883801A0 (en) 2001-11-13 2001-11-13 Dna sequences for human angiogenesis genes v
AU2002951032A AU2002951032A0 (en) 2002-08-28 2002-08-28 Dna sequence for a human angiogenesis gene vii
PCT/AU2002/001282 WO2003027285A1 (en) 2001-09-27 2002-09-19 Dna sequences for human angiogenesis genes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010037197A Division JP2010187671A (ja) 2001-09-27 2010-02-23 ヒト血管形成遺伝子に対するｄｎａ配列

Publications (3)

Publication Number Publication Date
JP2005505274A JP2005505274A (ja) 2005-02-24
JP2005505274A5 true JP2005505274A5 (enExample) 2006-01-05
JP4486815B2 JP4486815B2 (ja) 2010-06-23

Family

ID=27542986

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003530854A Expired - Fee Related JP4486815B2 (ja) 2001-09-27 2002-09-19 ヒト血管形成遺伝子に対するｄｎａ配列
JP2010037197A Pending JP2010187671A (ja) 2001-09-27 2010-02-23 ヒト血管形成遺伝子に対するｄｎａ配列

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010037197A Pending JP2010187671A (ja) 2001-09-27 2010-02-23 ヒト血管形成遺伝子に対するｄｎａ配列

Country Status (6)

Country Link
US (2) US20050112574A1 (enExample)
EP (1) EP1430126A4 (enExample)
JP (2) JP4486815B2 (enExample)
CA (1) CA2461372C (enExample)
NZ (3) NZ554534A (enExample)
WO (1) WO2003027285A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ554534A (en) * 2001-09-27 2008-10-31 Bionomics Ltd DNA sequences for human angiogenesis genes
AU2003901511A0 (en) * 2003-03-28 2003-04-17 Bionomics Limited Nucleic acid molecules associated with angiogenesis II
EP1654383A1 (en) * 2003-08-08 2006-05-10 Licentia, Ltd. Materials and methods for colorectal cancer screening, diagnosis, and therapy
JP2005073621A (ja) * 2003-09-01 2005-03-24 Japan Science & Technology Agency 脳腫瘍マーカーと脳腫瘍の診断方法
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
JP4685369B2 (ja) * 2004-04-30 2011-05-18 独立行政法人科学技術振興機構 関節リウマチ診断用試薬
US7667028B2 (en) 2004-05-10 2010-02-23 Bionomics Limited Compositions and methods for angiogenesis-related molecules and treatments
AU2005270734B2 (en) * 2004-08-09 2011-03-24 Bionomics Limited Compositions and methods for angiogenesis-related molecules and treatments
WO2006016692A1 (ja) * 2004-08-10 2006-02-16 Sumitomo Chemical Company, Limited ノックアウト非ヒト動物
FR2884258A1 (fr) * 2005-04-07 2006-10-13 Pharmamens Sarl Mesure de l'activite specifique de la glyoxalase i comme nouvel outil diagnostic/pronostic dans la pathologie du diabete et des processus du vieillissement
EP2332984A3 (en) * 2005-09-30 2011-10-12 Universiteit Maastricht Tumor angiogenesis associated genes and a method for their identification
AU2006350507A1 (en) * 2006-11-09 2008-05-15 Unibioscreen S.A. Targeting of alpha-1 or alpha-3 subunit of Na+, K+-ATPase in the treatment of proliferative diseases
US20100168382A1 (en) * 2007-06-12 2010-07-01 Vladimir Berezin Neuroplastin derived peptides
KR20090020897A (ko) 2007-08-24 2009-02-27 삼성전자주식회사 외부기기의 제어명령에 따라 제어되는 무선 영상시스템,무선 영상수신기 및 무선 영상시스템 제어방법
WO2009079762A1 (en) 2007-12-21 2009-07-02 Genesis Group Inc. Diagnostic test for cardiomyopathy
US8651916B2 (en) * 2010-01-18 2014-02-18 Disney Enterprises, Inc. System and method for generating realistic eyes
WO2011099435A1 (ja) * 2010-02-12 2011-08-18 日東紡績株式会社 Ｋｕ８６とその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法
WO2012026472A1 (ja) 2010-08-24 2012-03-01 旭化成ケミカルズ株式会社 内燃機関の窒素酸化物の削減方法及びその装置
US10457935B2 (en) 2010-11-12 2019-10-29 Gen9, Inc. Protein arrays and methods of using and making the same
ES2737957T3 (es) 2011-08-26 2020-01-17 Gen9 Inc Composiciones y métodos para el ensamblaje de alta fidelidad de ácidos nucleicos
US9150853B2 (en) 2012-03-21 2015-10-06 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
EP2841601B1 (en) 2012-04-24 2019-03-06 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
WO2016168694A1 (en) * 2015-04-15 2016-10-20 Ohio State Innovation Foundation Engineered calmodulin for treatment of ryanopathies
WO2019178059A1 (en) * 2018-03-13 2019-09-19 Georgetown University ENHANCING CHEMOTHERAPY IN MEDULLOBLASTOMA AND GLIOBLASTOMA WITH HIGH BASAL p53 LEVELS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
AUPM425294A0 (en) * 1994-03-04 1994-03-31 Australian National University, The In-vitro angiogenesis assay
EP1248798A2 (en) * 1999-08-18 2002-10-16 Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. Human dna sequences
FR2798674B1 (fr) * 1999-09-21 2004-01-30 Mahmood Salman Al Procede d'identification de nouveaux genes impliques dans la regulation de l'angiogenese, etude de ces genes et leur utilisation a des fins therapeutiques
CA2389751A1 (en) * 1999-11-01 2001-05-10 Curagen Corporation Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
NZ554534A (en) * 2001-09-27 2008-10-31 Bionomics Ltd DNA sequences for human angiogenesis genes
AU2002351828A1 (en) * 2001-11-05 2003-05-19 Deutsches Krebsforschungszentrum Novel genetic markers for leukemias

Similar Documents

Publication Publication Date Title
AU2024203581A1 (en) Oligonucleotides for reduction of PD-L1 expression
CN101946009A (zh) 用于心血管疾病的生物标记物
JP2010524427A (ja) 慢性移植片機能障害のためのバイオマーカー
JP2005520521A (ja) 統合失調症の診断および処置方法
JP2006518991A5 (enExample)
KR102885025B1 (ko) 유전적 조절
WO2002052006A1 (fr) Methode permettant d'examiner une maladie allergique
JP6721189B2 (ja) ｖＷＦに結合するＤＮＡアプタマー
WO2022048577A1 (zh) 抗人emc10的单克隆抗体在制备预防和/或治疗代谢性疾病的产品中的应用
JP7177439B2 (ja) 炎症促進因子発現抑制剤、その有効成分のスクリーニング方法、該方法に有用な発現カセット、診断薬、及び診断方法
JP2019513736A (ja) Ｂｃｋｄｈを調整する方法
CN116762010A (zh) 用于选择高质量干细胞的标记物，以及使用其选择高质量干细胞的方法
CN107326067B (zh) 一种非酒精性脂肪肝的miRNA标记物
EP2573169B1 (en) Cartilage-specific hif-2 transgenic mouse as an animal model for arthritis, and use thereof
JP2009523004A5 (enExample)
KR102034929B1 (ko) Nckap1 단백질 또는 상기 단백질을 암호화하는 유전자를 포함하는 신경계 퇴행성질환의 예방 또는 치료용 약학적 조성물
JP2004290197A5 (enExample)
JP2004503238A5 (enExample)
US20220349008A1 (en) Novel genetic markers for postural orthostatic tachycardia syndrome (pots) and methods of use thereof for diagnosis and treatment of the same
AU2008318311A1 (en) FGF9-related methods for treating anxiety
KR101556403B1 (ko) 지방간, 비만 및 당뇨병과 관련된 유전자 및 그의 용도
KR102916085B1 (ko) 뇌전증 관련 불안 장애에 대한 치료 표적 및 치료용 바이오 마커로서 il-17a의 용도
JP2007505825A5 (enExample)
WO2006016571A1 (ja) 子宮内膜症治療剤
JP2005503123A5 (enExample)